Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice (Q38292063)

1 September 2017

Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice (English)

1 reference

1 September 2017

0 references

0 references

0 references

1 reference

1 reference

Nair Sreejayan

1

1 reference

1 September 2017

Feng Dong

2

1 reference

1 September 2017

Machender R Kandadi

3

1 reference

1 September 2017

Xiaoping Yang

4

1 reference

1 September 2017

Jun Ren

5

1 reference

1 September 2017

3 April 2008

1 reference

1 September 2017

1 reference

1 September 2017

16

1 reference

1 September 2017

6

1 reference

1 September 2017

1331-1337

1 reference

Involvement of endoplasmic reticulum stress in insulin resistance and diabetes

1 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Insulin and insulin resistance: impact on blood pressure and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Role of chromium in human health and in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Recent advances in the nutritional biochemistry of trivalent chromium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

A newly synthetic chromium complex--chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Insulin-sensitizing and cholesterol-lowering effects of chromium (D-Phenylalanine)3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Fat in the liver and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.217

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.217

1 reference

release_cgkm34uysffaphwnuts4o2ouja

1 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cgkm34uysffaphwnuts4o2ouja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference